FDA Proposes Guidelines to Expedite Cell and Gene Therapy Development

The U.S. Food and Drug Administration has released new draft guidance aimed at streamlining the development process for cell and gene therapies. This initiative seeks to help companies bring these advanced treatments to patients more quickly by utilizing existing scientific and regulatory understanding, while still upholding safety standards.